The ROX coupler: Creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 5, 2015, Pages 880-886

  Foran, John P ^a,b   Jain, Ajay K ^c   Casserly, Ivan P ^d   Kandzari, David E ^e   Rocha Singh, Krishna J ^f   Witkowski, Adam ^g   Katzen, Barry T ^h   Deaton, David ⁱ   Balmforth, Peter ^j   Sobotka, Paul A ^j,k  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c LONDON CHEST HOSPITAL   (United Kingdom)

^d MATER PRIVATE HOSPITAL   (Ireland)

^e PIEDMONT HEART INSTITUTE   (United States)

^f ST JOHN'S HOSPITAL   (United States)

^g INSTITUTE OF CARDIOLOGY   (Poland)

^h BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

ⁱ PC   (United States)

^j ROX Medical Inc   (United States)

^k OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

arterial compliance; arteriovenous anastomosis; uncontrolled hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANASTOMOTIC DEVICE; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS FISTULA; ARTERY COMPLIANCE; ARTICLE; CATHETER; CATHETERIZATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FLUOROSCOPY; GUIDE WIRE; GUIDING CATHETER; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; NONHUMAN; PHLEBOGRAPHY; RANDOMIZED CONTROLLED TRIAL; ROX COUPLER; SELF EXPANDING STENT; SHEEP; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE; VASCULAR ACCESS; ANASTOMOSIS; ANIMAL; BLOOD PRESSURE; DEVICES; ILIAC ARTERY; ILIAC VEIN; PATHOPHYSIOLOGY; SUTURING METHOD; VASCULAR PATENCY; VASCULAR SURGERY;

ANASTOMOSIS, SURGICAL; ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION; ILIAC ARTERY; ILIAC VEIN; SUTURE TECHNIQUES; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 84925296908     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25707     Document Type: Article

References (23)

1. Irvin MR, Shimbo D, Mann DM, et al. Prevalence and correlates of low medication adherence in apparent treatment resistant hypertension. J Clin Hypertens (Greenwich) 2012; 14: 694-700.
2. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A,. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 2005; 23: 2093-2100.
3. Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountokalakis TD,. Adherence to antihypertensive treatment: A critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005; 12: 243-249.
4. Romanelli RJ, Schiro TA, Jukes T, Wong KS, Ishisaka DY,. Disparities in blood pressure control within a community-based provider network: An exploratory analysis. Ann Pharmacother 2011; 45: 1473-1482.
5. Persell SD,. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011; 57: 1076-1080.
6. Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125: 1635-1642.
7. Pimenta E, Calhoun DA,. Resistant hypertension: Incidence, prevalence, and prognosis. Circulation 2012; 125: 1594-1596.
8. Brambilla G, Bombelli M, Seravalle G, et al. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: Data from the BP-CARE study. J Hypertens 2013; 31: 2018-2024.
9. Bangalore S, Fayyad R, Laskey, et al. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med 2014; 127: 71-81.
10. Acelajado MC, Pisoni R, Dudenbostel T, et al. Refractory hypertension: Definition, prevalence and patient characteristics. J Clin Hypertens (Greenwich) 2012; 14: 7-12.
11. Faul J, Schoors D, Brouwers S, et al. Creation of an iliac arteriovenous shunt lowers blood pressure in chronic obstructive pulmonary disease patients with hypertension. J Vasc Surg 2014; 59: 1078-1083.
12. Cooper CB, Celli B,. Venous admixture in COPD: Pathophysiology and therapeutic approaches. COPD 2008; 5: 376-381.
13. Burchell AE, Lobo MD, Sulke N, Sobotka PA, Paton JFR,. Arteriovenous anastomosis: Is this the way to control hypertension? Hypertension 2014; 64: 6-12.
14. Faul JL, Galindo J, Posadas-Valay R, et al. An arteriovenous fistula increases exercise capacity in patients with COPD. Chest 2010; 138: 52-57.
15. Bertog SC, Kolmer C, Kleschnew S, et al. Percutaneous femoral arteriovenous shunt creation for advanced chronic obstructive pulmonary disease. Circ Cardiovasc Interv 2012; 5: 118-126.
16. Faul JL, Smyth RJ, Cormican LJ, Burke CM,. Letter by Faul et al regarding article, "percutaneous femoral arteriovenous shunt creation for advanced chronic obstructive pulmonary disease: A single-center safety and efficacy study. Circ Cardiovasc Interv 2012; 5: e45.
17. Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW,. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant 2011; 26: 3296-3302.
18. Malik J, Tuka V, Mokrejsova M, Holaj R, Tesar V,. Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res 2009; 58: 613-621.
19. Coentrão L, Santos-Araújo C, Dias C, Neto R, Pestana M,. Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: A retrospective cohort study. BMC Nephrol 2012; 13: 88.
20. Thomson BKA, Huang SHS, Chan C, Urquahart B, Skanes A, Lindsay RM,. Nocturnal home hemodialysis associates with improvement of electrocardiographic features linked to sudden cardiac death. ASAIO J 2014; 60: 99-105.
21. MacRae JM, Pandeya S, Humen DP, Krivitski N, Lindsay RM,. Arteriovenous fistula-associated high-output cardiac failure: A review of mechanisms. Am J Kidney Dis 2004; 43: e17-e22.
22. Masugata H, Senda S, Inukai M, Himoto T, Hosomi N, Imachi H, Murao K, Okada H, Goda F,. Relationship between arterial stiffness and variability in systolic blood pressure during a single clinic visit in patients with hypertension. J Int Med Res 2013; 41: 325-333.
23. Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401.